September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Repeated Flicker electroretinograms recordings before and after intravitreal ranibizumab injection in eyes with central retinal vein occlusion
Author Affiliations & Notes
  • Shunsuke Yasuda
    Ophthalmology, Nagoya Univ Graduate Sch of Med, Nagoya, Aichi, Japan
  • Shinji Ueno
    Ophthalmology, Nagoya Univ Graduate Sch of Med, Nagoya, Aichi, Japan
  • Shu Kachi
    Ophthalmology, Nagoya Univ Graduate Sch of Med, Nagoya, Aichi, Japan
  • Taro Kominami
    Ophthalmology, Nagoya Univ Graduate Sch of Med, Nagoya, Aichi, Japan
  • Ayami Nakanishi
    Ophthalmology, Nagoya Univ Graduate Sch of Med, Nagoya, Aichi, Japan
  • Chang-Hua Piao
    Ophthalmology, Nagoya Univ Graduate Sch of Med, Nagoya, Aichi, Japan
  • Hiroko Terasaki
    Ophthalmology, Nagoya Univ Graduate Sch of Med, Nagoya, Aichi, Japan
  • Footnotes
    Commercial Relationships   Shunsuke Yasuda, None; Shinji Ueno, None; Shu Kachi, None; Taro Kominami, None; Ayami Nakanishi, None; Chang-Hua Piao, None; Hiroko Terasaki, None
  • Footnotes
    Support  JSPS KAKENHI Grant Number 26861444
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 3598. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Shunsuke Yasuda, Shinji Ueno, Shu Kachi, Taro Kominami, Ayami Nakanishi, Chang-Hua Piao, Hiroko Terasaki; Repeated Flicker electroretinograms recordings before and after intravitreal ranibizumab injection in eyes with central retinal vein occlusion. Invest. Ophthalmol. Vis. Sci. 2016;57(12):3598.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The implicit times of the flicker electroretinograms (ERGs) have been shown to be significantly correlated with the degree of retinal ischemia in eyes with central retinal vein occlusion (CRVO). We have reported that the implicit times of the flicker ERGs were significantly shortened one month after the intravitreal injection of ranibizumab (IVR). The aim of this study was to determine whether repeated recordings of flicker ERGs before and after IVR can be used to monitor the degree of retinal ischemia.

Methods : We reviewed the medical records of 19 consecutive patients with macular edema secondary to CRVO who had received IVR therapy at the Nagoya University Hospital from November 2013 to December 2014 and were followed for more than 6 months. All patients received a single IVR, and the effects were evaluated monthly by the best-corrected visual acuity and the foveal thickness determined by optical coherence tomography. Flicker ERGs were recorded monthly with the RETeval system before and after the IVR. The pupils were dilated before each ERG recording. Additional injections were given when the macular edema recurred.

Results : The mean implicit times of the flicker ERGs at the baseline, and at 1, 2, 3, 4, 5, and 6 months after the initial treatment were 32.2±2.6ms, 30.7±2.2ms, 30.3±2.2ms, 30.5±2.1ms, 30.7±2.8ms, 30.7±2.5ms, and 30.7±2.6ms respectively. All of the implicit times were significantly shorter than that at the baseline. (P<0.05, paired t tests). The implicit time of a case that converted from non-ischemic to ischemic type during the follow-up period was markedly prolonged compared to that at the baseline (32.6 vs. 28.7ms). When a recurrence of macular edema occurred (35 re-injections in 16 eyes), the mean implicit times of the flicker ERGs were significantly longer than that at 1 month before the recurrence. (32.0±2.6ms vs. 31.3±2.5ms, P=0.04, paired t test).

Conclusions : Repeated flicker ERG recordings before and after IVR can be used to monitor the degree of retinal ischemia in CRVO eyes.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×